Home/Filings/4/0000200406-25-000143
4//SEC Filing

REED JOHN C 4

Accession 0000200406-25-000143

CIK 0000200406other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:10 PM ET

Size

8.4 KB

Accession

0000200406-25-000143

Insider Transaction Report

Form 4
Period: 2025-05-01
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2025-05-0125,25525,255 total
    Common Stock (25,255 underlying)
  • Tax Payment

    Common Stock

    2025-05-01$156.31/sh11,002$1,719,72329,795 total
  • Exercise/Conversion

    Common Stock

    2025-05-01+25,25540,797 total
Footnotes (2)
  • [F1]Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
  • [F2]Shares withheld for payment of taxes upon vesting of RSUs.

Issuer

JOHNSON & JOHNSON

CIK 0000200406

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001181561

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:10 PM ET
Size
8.4 KB